PTEN antibody | knockout validation | Cell Signaling 9559

This is a knockout-validated antibody summary, based on the publications "Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling" [1] and "PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth" [2], "PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer" for western blot knockout validation (see [3] figure 2d, 2h), "Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes" for western blot knockout validation (see figure 2b [4] ), "Clinicopathologic features of TDO2 overexpression in renal cell carcinoma" for western blot knockout validation (figure 3e) [5]. Article "Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy" indicates knockout validation of this article for western blot (see figure 5a) [6], and "AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor development" for western blot knockout validation (figure 1a,5g, s4a) [7]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG

Company: Cell Signaling

Antibody: PTEN

Catalog number: 9559

Summary: Mouse monoclonal IgG against a synthetic peptide corresponding to the carboxy-terminal sequence of human PTEN. Reacts with human, mouse, rat, and monkey. Suitable for western blot, immunoprecipitation, and immunohistochemistry (paraffin).

publication "Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling"
Validation Method

Immunohistochemistry | Western blot (see figure 5a of [6] )

Sample

Control and CRISPR/Cas9 targeting PTEN Wistar rats brains. Animals were perfused transcardially with 4% paraformaldehyde/PBS (4% PFA) and brain samples were post-fixed overnight in 4% PFA. Brains were sectioned at 65 µm thickness on a vibratome (Leica VT 1000S) and processed as free-floating sections.

Primary incubation

1:50 dilution.

Detection

Zeiss Axio imager M2 microscope with Apotome with 488/546/350 nm filter cubes and the X-Cite series 120Q light source.

Figure

Please see Figure 1c in the article [1].

publication "PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth"

Western blot detection of Pten from Pten+/+ and Pten−/− MEFs. See Figure 2a in [2].

References
  1. Chen F, Rosiene J, Che A, Becker A, LoTurco J. Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling. Development. 2015;142:3601-11 pubmed publisher
  2. Kuchay S, Giorgi C, Simoneschi D, Pagan J, Missiroli S, Saraf A, et al. PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth. Nature. 2017;546:554-558 pubmed publisher
  3. Brunner A, Suryo Rahmanto A, Johansson H, Franco M, Viiliäinen J, Gazi M, et al. PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer. elife. 2020;9: pubmed publisher
  4. Mao N, Gao D, Hu W, Hieronymus H, Wang S, Lee Y, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18:1577-1586 pubmed publisher
  5. Pham Q, Taniyama D, Sekino Y, Akabane S, Babasaki T, Kobayashi G, et al. Clinicopathologic features of TDO2 overexpression in renal cell carcinoma. BMC Cancer. 2021;21:737 pubmed publisher
  6. Anker J, Naseem A, Mok H, Schaeffer A, Abdulkadir S, Thumbikat P. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nat Commun. 2018;9:1591 pubmed publisher
  7. Wan X, Zhou M, Huang F, Zhao N, Chen X, Wu Y, et al. AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor development. Cell Death Dis. 2021;12:172 pubmed publisher